Related Experiment Video
Updated: Jul 18, 2026

Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses
Published on: February 27, 2026
Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV)
Chung K Chu1, Srinivas Gadthula, Xin Chen
1The University of Georgia, College of Pharmacy, Athens, GA, USA. dchu@rx.uga.edu
Abstract:
The recent outbreak of severe acute respiratory syndrome (SARS), which is an acute respiratory illness, is caused by newly discovered SARS coronavirus (SARS-CoV). Herein we describe the antiviral activity of several classes of nucleoside analogues evaluated against SARS-CoV in Vero 76 cells, some of which exhibited moderate activity.
More Related Videos
Related Concept Videos
Antiviral Nucleoside Inhibitors
Coronavirus
Inhibitors Of Virion Release
Inhibitors of Viral Protein Synthesis
Subviral Agents
Inhibitors of Virion Maturation and Assembly

